Search Results 1251-1260 of 17176 for monoclonal antibody
The purpose of this study is to determine the cellular and mechanistic basis of bone marrow hematopoietic dysfunction in untreated Monoclonal B Cell ...
Have received any monoclonal antibody therapy directed at treatment of the patient's malignancy within 2 weeks prior to anticipated first dose. Have ...
Serum monoclonal protein >= 1.0 g/dL; > 200 mg of monoclonal protein in the ... Monoclonal bone marrow plasmacytosis > 30% (evaluable disease). Prior ...
What is the significance of the BNT162b2 vaccine reportedly causing both antibodies and T cells to be made by the host? The immune system has two arms: humoral ...
Mayo Clinic has produced numerous videos to help people understand the transplant process and how research is helping overcome antibody barriers in transplant.
Known hypersensitivity to another monoclonal antibody that cannot be controlled with standard measures (e.g., antihistamines and corticosteroids) or known ...
This is a Phase I/II study designed to evaluate if experimental anti-TIGIT/anti-PD-1 bispecific antibody rilvegostomig (AZD2936) is safe, tolerable and ...
Treatment (within 90 days of screening) with monoclonal antibodies directed towards PCSK9. The above information is not intended to contain all ...
Monoclonal antibodies: at least 3 half-lives of the antibody after the last dose; Radiation therapy (RT): patients must have had their last fraction of ...
... antibody (HBcAb) test at screening, are eligible for the study if active HBV infection is ruled out on the basis of HBV deoxyribonucleic acid (DNA) viral ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.